跳至主要内容
临床试验/CTRI/2022/07/043751
CTRI/2022/07/043751尚未招募未知

Real-world evaluation of safety and effectiveness of 2.3% hypertonic saline soft mist spray (Nasoclear PureHaleTM) in sino-nasal symptoms

Zydus Healthcare Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Data of a patient will be copied in the data collection form only if:
  • 1. Patient had an indication for application of hypertonic saline nasal sprays, including but not limited to, e.g., viral, bacterial, or allergic rhinitis, acute or chronic rhinosinusitis
  • 2. The patient had symptoms of nasal congestion at his/her initial visit (Visit 0) at the medical center.
  • 3. The Total Nasal Symptom Score (TNSS) of the patient was recorded as >= 5 at visit 0.
  • 4. The patient was eligible to receive and was prescribed Nasoclear PureHaleTM as per the physicianâ??s discretion.

排除标准

  • Not applicable

研究者

相似试验